Assessing the Use of Rituximab in Hospitalized Neuroscience Patients: a Retrospective Analysis

Update Item Information
Identifier EBP2016_poster_CAREY
Title Assessing the Use of Rituximab in Hospitalized Neuroscience Patients: a Retrospective Analysis
Creator Carey, Jessica R.; Sederholm, Benjamin H.
Subject Evidence-Based Practice; Rituximab; Multiple Sclerosis; Myesthenia Gravis; Neuromyelitis Optica; Polyneuropathies; Demyelinating Diseases; Autoimmune Diseases of the Nervous System; Clinical Protocols; Guideline Adherence; Retrospective Studies; Treatment Outcome; Poster
Description There is no current FDA indication for the use of rituximab in autoimmune neurological disorders. A growing body of literature supports the use for rituximab in Multiple Sclerosis, Myasthenia Gravis, Neuromyelitis Optica and related conditions.
Relation is Part of Evidence Based Pharmacy - 2016
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date Digital 2016
Date 2016
Type Text
Format application/pdf
Source Evidence-Based Practice 2016
Rights https://rightsstatements.org/page/InC/1.0/
Language eng
ARK ark:/87278/s6c86ns4
Setname ehsl_ebp
ID 1399579
Reference URL https://collections.lib.utah.edu/ark:/87278/s6c86ns4
Back to Search Results